Reference health
Mortality of lymphoma and myeloma in China, 2004–2017: an observational study
29/29 checkable references clean · checked 2026-07-24
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 29 checked references that resolve
resolves10.1182/blood-2016-01-643569
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
resolves10.1001/jamaoncol.2018.2706
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
resolves10.3322/caac.21357
2016 US lymphoid malignancy statistics by World Health Organization subtypes
resolves10.1001/jama.2016.20324
Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014
resolves10.1016/S0140-6736(15)00551-6
Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
resolves10.1016/S2214-109X(16)30360-6
National and regional under-5 mortality in China in the past two decades
resolves10.1016/S0140-6736(15)00554-1
Under-5 mortality in 2851 Chinese counties, 1996–2012: a subnational assessment of achieving MDG 4 goals in China
resolves10.2471/BLT.15.153148
An integrated national mortality surveillance system for death registration and mortality surveillance, China
resolves10.1186/s12963-015-0051-3
Propensity score weighting for addressing under-reporting in mortality surveillance: a proof-of-concept study using the nationally representative mortality data in China
resolves10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
resolves10.1038/bjc.2015.94
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network
resolves10.1111/bjh.15532
Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States
resolves10.1093/annonc/mdx342
Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013
resolves10.1016/j.ejca.2018.07.005
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
resolves10.1016/S0140-6736(17)32152-9
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
resolves10.1016/S0140-6736(17)33326-3
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
resolves10.1016/S2214-109X(18)30127-X
Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
resolves10.1186/s12913-016-1426-2
Correlates of unequal access to preventive care in China: a multilevel analysis of national data from the 2011 China Health and Nutrition Survey
resolves10.1186/1472-6963-14-305
Financial protection effects of modification of China’s New Cooperative Medical Scheme on rural households with chronic diseases
resolves10.1377/hlthaff.2009.0989
China’s Rural-Urban Care Gap Shrank For Chronic Disease Patients, But Inequities Persist
resolves10.1186/s12939-017-0706-8
Socioeconomic inequalities of outpatient and inpatient service utilization in China: personal and regional perspectives
resolves10.1016/S0140-6736(12)60278-5
Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study
resolves10.1016/S1470-2045(14)70029-4
Challenges to effective cancer control in China, India, and Russia
The 1 reference without a DOI — listed, not checked
no DOI — not checkedWang L, Wang LJ, Cai Y, Ma LM, Zhou MG. Analysis of under-reporting of mortality surveillance from 2006 to 2008 in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45(12):1061–4.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1186/s13045-019-0706-9"><img src="https://citestamp.com/citestamped/10.1186/s13045-019-0706-9/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1186/s13045-019-0706-9)